Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA · NYSE · CIK 0000818686 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

39 Form 4 transaction lines observed in the same window
22 sales · 17 option, withholding, award, gift or other lines

Last qualifying purchase2025-09-05 · McAvoy David R. · $21.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Weiss AmirChief Accounting Officer
▼○▼
Lippman EvanEVP, Business Development
○▼▼
Shields MatthewEVP, Global Operations
○▼▼
Savage BrianInterim Chief Legal Officer
○▼
MIGNONE ROBERTODirector
○▼
Satchi-Fainaro RonitDirector
○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 12 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-09-05 · McAvoy David R..

Recent Form 4 activity

0Purchases
58Sales
59Other Form 4 lines
65SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING22 sale line(s) · context only
OTHER17 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
29,848,805
Previous report
31,478,314
Avg daily volume
5,530,389
Days to cover
5.4

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-09-05McAvoy David R.Purchase (P)Ordinary Shares1,113USD 18.86USD 20,991SEC filing ↗

Form 4 evidence

117 transaction lines in the latest 365-day window; 619 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-18Savage BrianSale (S)Ordinary Shares7,342USD 38.85USD 285,227SEC filing ↗
2026-09-18Savage BrianOption exercise / conversion (M)Ordinary Shares4,503USD 34.70USD 156,254SEC filing ↗
2026-09-18MIGNONE ROBERTOSale (S)Ordinary Shares367,600USD 39.06USD 14,358,456SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-18Savage BrianSale (S)Ordinary Shares7,342USD 38.85USD 285,227SEC filing ↗
2026-09-18Savage BrianOption exercise / conversion (M)Ordinary Shares4,503USD 34.70USD 156,254SEC filing ↗
2026-09-18MIGNONE ROBERTOSale (S)Ordinary Shares367,600USD 39.06USD 14,358,456SEC filing ↗
2026-08-21Weiss AmirSale (S)Ordinary Shares9,445USD 37.62USD 355,276SEC filing ↗
2026-08-21Weiss AmirOption exercise / conversion (M)Ordinary Shares2,500USD 19.61USD 49,025SEC filing ↗
2026-08-21Satchi-Fainaro RonitSale (S)Ordinary Shares415USD 37.25USD 15,459SEC filing ↗
2026-08-17Lippman EvanSale (S)Ordinary Shares18,600USD 36.57USD 680,202SEC filing ↗
2026-08-05Zaks Tal ZviSale (S)Ordinary Shares17USD 34.87USD 593SEC filing ↗
2026-08-03Jover PlacidSale (S)Ordinary Shares12,827USD 34.88USD 447,406SEC filing ↗
2026-08-03Jover PlacidOption exercise / conversion (M)Ordinary Shares12,827USD —USD —SEC filing ↗
2026-08-03Hughes Eric ASale (S)Ordinary Shares25,578USD 34.88USD 892,161SEC filing ↗
2026-08-03Hughes Eric AOption exercise / conversion (M)Ordinary Shares52,744USD —USD —SEC filing ↗
2026-06-18Shields MatthewSale (S)Ordinary Shares9,989USD 32.19USD 321,546SEC filing ↗
2026-06-11Kalif Eliyahu SharonSale (S)Ordinary Shares106,563USD 34.10USD 3,633,798SEC filing ↗
2026-06-05Zaks Tal ZviOption exercise / conversion (M)Ordinary Shares14,492USD —USD —SEC filing ↗
2026-06-05Satchi-Fainaro RonitOption exercise / conversion (M)Ordinary Shares14,492USD —USD —SEC filing ↗
2026-06-05Nisen PerryOption exercise / conversion (M)Ordinary Shares14,492USD —USD —SEC filing ↗
2026-06-05MIGNONE ROBERTOOption exercise / conversion (M)Ordinary Shares14,492USD —USD —SEC filing ↗
2026-06-05Lichtenstein ChenOption exercise / conversion (M)Ordinary Shares14,492USD —USD —SEC filing ↗
2026-06-05LIEBERMAN GERALD MOption exercise / conversion (M)Ordinary Shares14,492USD —USD —SEC filing ↗
2026-06-05Francis Richard DSale (S)Ordinary Shares6,153USD 34.35USD 211,356SEC filing ↗
2026-06-05Francis Richard DOption exercise / conversion (M)Ordinary Shares13,043USD —USD —SEC filing ↗
2026-06-05Elstein AmirOption exercise / conversion (M)Ordinary Shares14,492USD —USD —SEC filing ↗
2026-06-05Crane Rosemary AOption exercise / conversion (M)Ordinary Shares14,492USD —USD —SEC filing ↗
2026-06-05BARER SOL JOption exercise / conversion (M)Ordinary Shares21,739USD —USD —SEC filing ↗
2026-06-03Shields MatthewSale (S)Ordinary Shares16,195USD 32.87USD 532,330SEC filing ↗
2026-06-03Shields MatthewOption exercise / conversion (M)Ordinary Shares16,195USD —USD —SEC filing ↗
2026-05-14Lippman EvanSale (S)Ordinary Shares41,658USD 35.58USD 1,482,192SEC filing ↗
2026-05-14Lippman EvanOption exercise / conversion (M)Ordinary Shares85,849USD —USD —SEC filing ↗
2026-05-14Kalif Eliyahu SharonSale (S)Ordinary Shares153,251USD 35.61USD 5,457,268SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerTEVA
CIK0000818686
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNYSE

Data coverage

Local Form 4 history619 transaction lines from 2020-02-09 to 2026-09-18
1 P purchase lines · 239 S sale lines · 379 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.